NYSE ARCA | ETF
Under normal market conditions, the fund seeks to achieve its investment objective by establishing long and short positions in the equity securities of companies that are involved in a publicly-announced significant corporate event, such as a merger or acquisition.
It's portfolio may include equity securities issued byU. S. and non-U.S. companies, including American Depositary Receipts (ADRs).
The fund may invest in securities issued by small, mid and large capitalization issuers.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| SPLK | Splunk Inc | Technology | Software - Infrastructure | 6.15% |
| ACI | Albertsons Companies | Consumer Defensive | Grocery Stores | 5.49% |
| AMED | Amedisys Inc | Healthcare | Medical Care Facilities | 4.71% |
| PXD | Pioneer Natural Resources Co | Energy | Oil & Gas E&P | 4.45% |
| X | United States Steel Corporation | Basic Materials | Steel | 4.43% |
| MRTX | Mirati Ther | Healthcare | Biotechnology | 4.20% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 4.02% |
| RPT | RPT Realty | Real Estate | REIT - Retail | 3.89% |
| NEBC | Nebula Caravel Acquisition Corp | Financial Services | Shell Companies | 3.54% |
| SOVO | Sovos Brands Inc | Consumer Defensive | Packaged Foods | 3.45% |
| AYX | Alteryx Inc | Technology | Software - Application | 3.05% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 3.05% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 3.04% |
| TGH | Textainer Group Holdings Ltd | Industrials | Rental & Leasing Services | 3.04% |
| ICVX | Icosavax Inc | Healthcare | Biotechnology | 3.02% |
| LBAI | Lakeland Bancorp Inc | Financial Services | Banks - Regional | 2.50% |
| CHS | Chicos FAS Inc | Consumer Cyclical | Apparel Retail | 2.49% |
| PNM | PNM Resources Inc | Utilities | Utilities - Regulated Electric | 2.48% |
| CPRI | Capri Holdings Ltd | Consumer Cyclical | Luxury Goods | 2.07% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 2.04% |